Clinical trial

Bronchial Blockers vs Double-Lumen Tubes in Obese Patients

Recruiting now · Not applicable · 1 countries · Registry ID NCT07031986

Recruiting nowNot applicableInterventional

What this study is about

The goal of this clinical trial is to evaluate the efficacy of bronchial blockers and double-lumen tubes in achieving one-lung ventilation in obese patients undergoing lung resections. The primary question it aims to answer is: • Is intraoperative hypoxia significantly different depending on the device used? Researchers will compare the use of bronchial blockers and double-lumen tubes to assess differences in efficacy and safety. Participants will not be required to perform any tasks.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 90 Years
SexAll
Healthy volunteersNot accepted
ConditionOne-lung Ventilation

Full registry criteria

Inclusion Criteria: * BMI ≥ 30 kg/m2 * Diagnostic or clinical suspicion of lung cancer * Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy, requiring one-lung ventilation. * Use of bronchial blocker or double-lumen tube for one-lung ventilation. Exclusion Criteria: * Patients with evident anatomic alterations, in which double-lumen tubes may be contraindicated. * Emergency surgeries.

Treatments and study arms

One-Lung ventilation with Double-Lumen Tube

Device

To achieve the required one-lung ventilation during lung resection, patients will be managed with a double-lumen tube.

One-Lung Ventilation with Bronchial Blocker

Device

To achieve the required one-lung ventilation during lung resection, patients will be managed with a bronchial blocker.

Primary outcomes

HypoxiaIntraoperative (both from anesthetic induction to one-lung ventilation, and during one-lung ventilation)

While its definition is somewhat arbitrary, the investigators consider hypoxia as SpO₂ \< 90%, while maintaining FiO₂ = 1.0, in accordance to our hospital guidelines.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Hospital Son Espases🇪🇸 Palma de Mallorca, Balearic Islands, Spain
Paulo Andrés Cano, MDContact